How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Surrogacy Market
- By Surrogacy Type: Traditional Surrogacy, Gestational Surrogacy
- By Service Provider: Fertility Clinics, Surrogacy Agencies, Legal and Consulting Services, Medical Tourism Facilitators
- By End User: Infertile Couples, Single Parents, Same-Sex Couples, Individuals with Genetic Disorders
- By Compensation Model: Commercial Surrogacy, Altruistic Surrogacy
- By Surrogate Compensation Structure: Fixed Fee, Performance-Based Incentives, Reimbursement Only
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Traditional Surrogacy leads By Surrogacy Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.169 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.177 →
Full report · locked preview
Everything inside the Surrogacy Market report
A complete, evidence-based study - 12 chapters and 118 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Circle Surrogacy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Growing Generations
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Simple Surrogacy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Surrogate Alternatives
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ConceiveAbilities
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Creative Family Connections
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Family Source Consultants
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Surrogacy International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →New Life Global Network
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Egg Donor & Surrogacy Agency
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Surrogacy Agency India
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Global Surrogacy Services
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Surrogate Parenting Services
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Surrogacy Solutions
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Fertility Source Companies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Traditional Surrogacy86.0
- Gestational Surrogacy14.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Circle Surrogacy19.4
- Growing Generations20.7
- Simple Surrogacy5.7
- Surrogate Alternatives11.8
- ConceiveAbilities8.2
- Creative Family Connections6.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.1
- Europe23.4
- Asia Pacific20.8
- Latin America14.5
- Middle East and Africa10.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Circle Surrogacy | 98 | 90 | 83 | 75 | 89 | 78 | 86 |
| Growing Generations | 92 | 84 | 81 | 69 | 81 | 70 | 80 |
| Simple Surrogacy | 82 | 73 | 65 | 79 | 77 | 69 | 74 |
| Surrogate Alternatives | 68 | 82 | 75 | 63 | 81 | 81 | 75 |
| ConceiveAbilities | 60 | 52 | 70 | 52 | 70 | 62 | 61 |
| Creative Family Connections | 46 | 64 | 56 | 54 | 47 | 65 | 55 |
| Family Source Consultants | 60 | 52 | 48 | 62 | 57 | 54 | 56 |
| Surrogacy International | 51 | 41 | 55 | 47 | 40 | 54 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Circle Surrogacy
- Growing Generations
- Simple Surrogacy
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Circle Surrogacy | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Growing Generations | ◐ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Simple Surrogacy | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Surrogate Alternatives | ✓ | ✓ | ◐ | − | ✓ | ◐ |
| ConceiveAbilities | − | − | − | ◐ | − | ◐ |
| Creative Family Connections | − | ◐ | − | − | − | − |
| Family Source Consultants | − | − | ◐ | ◐ | − | ◐ |
| Surrogacy International | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Surrogacy Type in North America, then scale across Surrogacy Market — a $524M beachhead inside a $7.86B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Traditional Surrogacy
Best fit — highest urgency & budget in Surrogacy Type.
Gestational Surrogacy
Strong fit — clear ROI and a fast path to value.
Enterprise buyers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surrogacy Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Service Provider & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Surrogacy Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Surrogacy Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Surrogacy Market is a resilient opportunity — $2.88B by 2033, compounding at 3.6%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.6% CAGR
Demand compounds through 2033, outpacing GDP across Surrogacy Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surrogacy Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Service Provider optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Surrogacy Market — a $3.21B market by 2033. Plan: grow share from 8.6% to 15.7%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.6% | 15.7% | At risk |
| Revenue | $266M | $505M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.1% | 45.9% | Behind |
| Customer retention | 87.6% | 97.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Surrogacy Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Service Provider capability
A defensible second engine — invest in Service Provider to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surrogacy Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Service Provider
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $55M capacity & capability investment
- Greenlight bolt-on M&A in Service Provider
- Authorise North America expansion plan
- Fund R&D program for Surrogacy Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Sales deck · value proposition
Win the Surrogacy Market conversation — a $3.86B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surrogacy Type
Goal Grow share in Surrogacy Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Surrogacy Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Surrogacy Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Human Capital Management (HCM) in SMB Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportStructural Heart Occluder Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportHuman Enhancement Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportStroke Imagine Processing Software Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportSpecialty Hospitals Market
Market size, share, segmentation and regional forecast.
$414M market · 2025 base year
View reportGynecology Software Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportGxP (GMP) Regulation Testing Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View report4-Chlorophenylhydrazine Hydrochloride Market
Market size, share, segmentation and regional forecast.
$897M market · 2025 base year
View reportRespirator Fit Testing Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportFertility Tracking Apps Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportQuantitative Respirator Fit Testing Market
Market size, share, segmentation and regional forecast.
$646M market · 2025 base year
View reportQualitative Respirator Fit Testing Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy